Paragraph 34 — part 2
Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness
A10-0123/2025 – Hildegard Bentele – § 34/2
Adopted
- For
- 566
- Against
- 60
- Abstained
- 23
roll-call vote at 13:15 · 87% of votes cast in favour
Roll call requested by Members · split vote by Members
The part voted on: ‘underlines that the sector is characterised by high levels of risk and that reducing the cost of investment failure in the EU is necessary for attracting large-scale capital investment; calls for dedicated support to ensure that biotechnology and biomanufacturing SMEs, start-ups and scale-ups can access sufficient funding and compete globally; stresses that cross-border investment barriers must be reduced to facilitate investment in biotechnology and biomanufacturing scale-ups;’
How the groups voted
A group’s line is the position at least two thirds of its voting MEPs took; otherwise it is shown as Divided. Groups from left to right.
| Group | For | Against | Abstained | of | Line |
|---|---|---|---|---|---|
| The Left | 12 | 25 | 1 | 38 | Divided |
| Greens | 47 | 0 | 4 | 51 | For |
| S&D | 117 | 0 | 0 | 117 | For |
| Renew | 68 | 0 | 0 | 68 | For |
| EPP | 173 | 2 | 0 | 175 | For |
| ECR | 64 | 2 | 6 | 72 | For |
| Patriots | 73 | 6 | 0 | 79 | For |
| ESN | 2 | 18 | 5 | 25 | Against |
| No group | 10 | 7 | 7 | 24 | — |
“of” = MEPs of the group who voted. Groups as they are now.
Every MEP
649 MEPs voted. Open a group, or filter above.
The Left 38 MEPs
Greens 51 MEPs
S&D 117 MEPs
Renew 68 MEPs
EPP 175 MEPs
ECR 72 MEPs
Patriots 79 MEPs
ESN 25 MEPs
No group 24 MEPs
“Votes in which an MEP voted differently from their group: on decision pages, against a line at least two thirds of the group took; in loyalty figures, against the position most of the group took.” = voted otherwise than a clear line (two thirds of its votes) of the group they sit in now. MEPs with no vote recorded are not listed.